UBS Group’s ENVUE MEDICAL INC NEW FEED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2
| Closed | -$57 | – | 10830 |
|
|
2026
Q1 | $57 | Sell |
2
-3
| -60% | -$78 | ﹤0.01% | 10190 |
|
|
2025
Q4 | $139 | Buy |
5
+2
| +67% | +$113 | ﹤0.01% | 10151 |
|
|
2025
Q3 | $198 | Sell |
3
-111
| -97% | -$10K | ﹤0.01% | 9817 |
|
|
2025
Q2 | $12.7K | Buy |
114
+71
| +165% | +$25.4K | ﹤0.01% | 8727 |
|
|
2025
Q1 | $17.6K | Buy |
43
+12
| +39% | +$6.61K | ﹤0.01% | 8314 |
|
|
2024
Q4 | $24.3K | Buy |
31
+30
| +3,000% | +$24.3K | ﹤0.01% | 7751 |
|
|
2024
Q3 | $910 | Buy |
+1
| New | +$873 | ﹤0.01% | 8781 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9268 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$4.07K | – | 9789 |
|
|
2023
Q4 | $4.07K | Sell |
3
-4
| -57% | -$5.89K | ﹤0.01% | 7905 |
|
|
2023
Q3 | $17.5K | Buy |
+7
| New | +$25K | ﹤0.01% | 6878 |
|
|
2023
Q2 | – | Sell |
-3
| Closed | -$12.6K | – | 9394 |
|
|
2023
Q1 | $12.6K | Buy |
+3
| New | +$19.4K | ﹤0.01% | 7436 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$9.88K | – | 9699 |
|
|
2022
Q3 | $13K | Buy |
+1
| New | +$15.6K | ﹤0.01% | 8050 |
|
|
2022
Q2 | – | Hold |
0
| – | -$4K | – | 10703 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9303 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9044 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$22K | – | 9879 |
|
|
2021
Q2 | $22K | Sell |
1
-1
| -50% | -$24.3K | ﹤0.01% | 7237 |
|
|
2021
Q1 | $56K | Buy |
+2
| New | +$61.5K | ﹤0.01% | 6429 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7628 |
|
|
2020
Q2 | – | Hold |
0
| – | -$5K | – | 8207 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7305 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7963 |
|
|
2019
Q3 | – | Hold |
0
| – | -$1K | – | 8155 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7724 |
|
|
2019
Q1 | – | Hold |
0
| – | -$16K | – | 8001 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6945 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6796 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7036 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6618 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7026 |
|
Other funds holding FEED
HF
VF
TSS
TRCT
GRP
UBS Group's FEED Position: Q2 2026 in Review
UBS Group sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2026, closing a stake of 2 shares — an estimated $57 sold.
UBS Group first reported a position in FEED in Q1 2021 and held it in 13 quarters. The position peaked at $56K in Q1 2021. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.
- UBS Group reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 2 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $57.
- UBS Group first reported a position in ENVUE MEDICAL INC NEW in Q1 2021 and held it in 13 quarters.
- UBS Group's ENVUE MEDICAL INC NEW position peaked at $56K in Q1 2021.
- 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.